Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 28, 2011; 17(36): 4076-4089
Published online Sep 28, 2011. doi: 10.3748/wjg.v17.i36.4076
Published online Sep 28, 2011. doi: 10.3748/wjg.v17.i36.4076
Figure 11 The expression of mRNA for cyclooxygenase-2, IL-1β, tumor necrosis factor-α and inducible form of nitric oxide synthase in colonic mucosa of intact rats (lane 1) those treated with vehicle (lane 2), aspirin (lane 3) and nitric oxide-aspirin (lane 4) at day 10 after induction of colitis.
Mean ± SE of 4 determinations in 4 rats. aP < 0.05 vs intact colonic mucosa; cP < 0.05 vs rats with trinitrobenzenesulfonic acid colitis administered with vehicle (Veh); eP < 0.05 vs vehicle and aspirin (ASA) groups. COX: Cyclooxygenase; TNF: Tumor necrosis factor; iNOS: Inducible form of nitric oxide synthase; M: Marker.
- Citation: Zwolinska-Wcislo M, Brzozowski T, Ptak-Belowska A, Targosz A, Urbanczyk K, Kwiecien S, Sliwowski Z. Nitric oxide-releasing aspirin but not conventional aspirin improves healing of experimental colitis. World J Gastroenterol 2011; 17(36): 4076-4089
- URL: https://www.wjgnet.com/1007-9327/full/v17/i36/4076.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i36.4076